Group 1 - The core announcement from Huajian Medical involves the establishment of two joint ventures, ETHK Inc. and ETHK HOLDINGS LIMITED, aimed at enhancing the global blockchain financial ecosystem through the "ETHK" brand [1][4] - The company is undergoing a significant rebranding, changing its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" [1][4] - The strategic shift towards blockchain finance is a result of long-term planning, with ETHK Inc. focusing on developing a decentralized financial platform and ETHK HOLDINGS LIMITED serving as a central hub for digital industry investment and mergers [6][9] Group 2 - The "ETHK" brand symbolizes a new digital financial ecosystem based on blockchain, emphasizing openness, transparency, and community governance [9] - Huajian Medical's strategy includes the tokenization of equity assets, particularly targeting high-quality Chinese assets for efficient global circulation and value discovery [9][12] - The company has acquired a 20.31% stake in Guofu Quantum, becoming its largest shareholder, which strengthens its compliance support in the blockchain finance sector [12] Group 3 - The concept of "on-chain stocks" represents a revolutionary trend in global finance, with Huajian Medical's approach being a unique "Chinese solution" that integrates technology, assets, funding, and compliance into a closed-loop blockchain financial ecosystem [10][12] - This approach contrasts with existing U.S. tokenization products, which often lack direct backing from the underlying companies, highlighting the potential for arbitrage opportunities [12] - Huajian Medical's ETHK ecosystem aims to meet the rigorous demands of high-frequency, high-value financial transactions, facilitating the globalization of Chinese assets through compliant and standardized methods [12][14] Group 4 - The strategic upgrade aligns with China's digital economy initiatives, which encourage technological innovation and digital transformation [13][14] - Huajian Medical's efforts are positioned to provide the necessary technological pathways and infrastructure support for the globalization of Chinese assets [14] - The ETHK ecosystem is expected to bridge traditional finance and blockchain finance, promoting the efficient circulation and value discovery of high-quality Chinese assets on a global scale [15]

Core Viewpoint - The company Huajian Medical (01931) is undergoing a strategic transformation by establishing two new companies in collaboration with ETHK Group, focusing on the tokenization of equity assets and the development of a global blockchain financial ecosystem [1][6]. Group 1: Company Developments - Huajian Medical announced the formation of ETHK Inc. and ETHK HOLDINGS LIMITED to enhance its global blockchain financial strategy, particularly in promoting "on-chain stocks" [1]. - The company plans to change its English name to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" to reflect its ambition to become a leader in digital industry innovation and blockchain technology [1]. - Following the announcement, Huajian Medical's stock price surged approximately 8%, closing at HKD 10.71, a significant increase from HKD 2.22 on July 2 [1]. Group 2: Industry Trends - Asset tokenization is emerging as a significant trend in global financial markets, with Galaxy Digital recently allowing shareholders to tokenize and hold GLXY stocks on-chain, marking a notable case of stock tokenization by a public company [4]. - The advantages of on-chain stocks include 24/7 trading, near-instant settlement, reduced transaction costs, and seamless global circulation, driving a revolution in traditional financial assets [4]. - A joint prediction by Boston Consulting Group and ADDX estimates that by 2030, the global Real World Asset (RWA) market will reach USD 16.1 trillion, accounting for 10% of global GDP [4]. Group 3: Strategic Vision - The strategic upgrade of Huajian Medical aims to systematically build the "ETHK" blockchain financial ecosystem, which includes five core pillars: technical infrastructure, financial product matrix, sustainable models, global compliance framework, and seamless user access [6][9]. - The establishment of the two joint ventures allows Huajian Medical to focus on technology platform development while integrating global quality resources through capital means, creating a self-sustaining growth model [9]. - The company's vision aligns with national policies promoting financial technology innovation and digital economic development, potentially providing new channels for global financing and circulation of high-quality Chinese assets [10].